Venus Concept Inc. (NASDAQ:VERO – Get Free Report) major shareholder Michael Willingham Masters sold 71,368 shares of the business’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $0.64, for a total transaction of $45,675.52. Following the completion of the sale, the insider now directly owns 22,383 shares in the company, valued at approximately $14,325.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Michael Willingham Masters also recently made the following trade(s):
- On Wednesday, October 2nd, Michael Willingham Masters sold 94,553 shares of Venus Concept stock. The stock was sold at an average price of $0.53, for a total transaction of $50,113.09.
Venus Concept Price Performance
Shares of VERO opened at $0.50 on Friday. The company has a market cap of $3.18 million, a price-to-earnings ratio of -0.07 and a beta of 0.51. Venus Concept Inc. has a 1-year low of $0.42 and a 1-year high of $2.43. The company’s fifty day simple moving average is $0.61 and its 200 day simple moving average is $0.66. The company has a current ratio of 1.99, a quick ratio of 1.30 and a debt-to-equity ratio of 9.72.
Hedge Funds Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its holdings in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the period. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 as of its most recent filing with the SEC. Institutional investors own 87.41% of the company’s stock.
Venus Concept Company Profile
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
See Also
- Five stocks we like better than Venus Concept
- Technology Stocks Explained: Here’s What to Know About Tech
- When Is the Best Time to Invest in Mutual Funds?
- CD Calculator: Certificate of Deposit Calculator
- Is NVIDIA Stock in a Correction or Consolidation?
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.